7 september 2021

Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.

Continue reading
#

Ardigen's feed news

Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
7 september 2021
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
Continue reading
Ardigen obtained a Great Place to Work certification
19 July 2021
Ardigen obtained a Great Place to Work certification
Continue reading
Ardigen and OncoArendi join forces for research collaboration
24 May 2021
Ardigen and OncoArendi join forces for research collaboration
Continue reading
Assessing off-target toxicity of cellular immunotherapies - CIMT 2021 poster
13 May 2021
Assessing off-target toxicity of cellular immunotherapies - CIMT 2021 poster
Continue reading
Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery
15 April 2021
Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery
Continue reading
Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet
April 13, 2021
Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet
Continue reading
Happy Easter holiday
02 April 2021
Happy Easter holiday
Continue reading
Ardigen promotes Michał Warchoł to the Management Board to strengthen AI expertise in the field of drug discovery.
March 11, 2021
Ardigen promotes Michał Warchoł to the Management Board to strengthen AI expertise in the field of drug discovery.
Continue reading
Conferences - where can you find us in February?
February 4, 2021
Conferences - where can you find us in February?
Continue reading
Go up